Banque Transatlantique’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$19.1M Buy
90,610
+6,432
+8% +$1.5M 0.41% 40
2026
Q1
$20.5M Buy
84,178
+8,169
+11% +$1.9M 0.49% 34
2025
Q4
$15.7M Sell
76,009
-1,859
-2% -$368K 0.38% 40
2025
Q3
$14.4M Sell
77,868
-908
-1% -$156K 0.35% 43
2025
Q2
$12.1M Sell
78,776
-2,517
-3% -$387K 0.33% 36
2025
Q1
$13.5M Sell
81,293
-7,289
-8% -$1.14M 0.41% 39
2024
Q4
$12.8M Buy
+88,582
New +$13.7M 0.32% 38

Other funds holding JNJ

Banque Transatlantique's JNJ Position: Q2 2026 in Review

Banque Transatlantique increased its Johnson & Johnson (JNJ) stake by 7.6% in Q2 2026, buying an estimated $1.5M and bringing the position to 90,610 shares worth $19.1M. The position accounts for 0.41% of the portfolio, ranked #40.

Banque Transatlantique first reported a position in JNJ in Q4 2024 and has held it in 7 quarters since. The position peaked at $20.5M in Q1 2026. 3,174 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Banque Transatlantique held 90,610 shares of Johnson & Johnson worth $19.1M as of Q2 2026.
  • Banque Transatlantique bought 6,432 Johnson & Johnson shares in Q2 2026, an estimated $1.5M.
  • Johnson & Johnson made up 0.41% of Banque Transatlantique's portfolio in Q2 2026, its #40 holding.
  • Banque Transatlantique first reported a position in Johnson & Johnson in Q4 2024 and has held it in 7 quarters since.
  • Banque Transatlantique's Johnson & Johnson position peaked at $20.5M in Q1 2026.
  • 3,174 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Banque Transatlantique's 13F filing for Q2 2026, filed 30 Jul 2026.